RNS Number : 4982G
Craven House Capital PLC
15 November 2022
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION (EU) 596/2014 AS IT FORMS PART OF DOMESTIC LAW IN THE UNITED KINGDOM BY VIRTUE OF THE EU (WITHDRAWAL) ACT 2018. 

Craven House Capital plc

 Investee company update: Garimon Ltd

Craven House Capital plc ("Craven House" or the "Company"), the AIM quoted investment company, provides the following update regarding its investee company Garimon Ltd ("Garimon").

The management of Garimon has transferred out the domain name www.onebas.com to a separate entity, Stormfjord Ltd ("Stormfjord"). Stormfjord has subsequently raised $0.52m in cash at a valuation of $5m. Craven House did not participate in the fundraising and as a result, its shareholding in Stormfjord is 26.2%.

The www.onebas.com domain was transferred out of Garimon in order to facilitate further fundraising activity focused on the domain.

Craven House continues to own 29.9% of Garimon which owns the domain name www.magazinos.com.

~ Ends ~

 For further information please contact:

Craven House Capital Plc

Mark Pajak

www.Cravenhousecapital.com

 

Tel: 0203 286 8130

 

 

SI Capital

Broker

Nick Emerson

www.sicapital.co.uk

Tel: 01483 413500

 

SPARK Advisory Partners Limited

Nominated Adviser

Matt Davis

www.Sparkadvisorypartners.com

 

 

Tel: 0203 368 3550

 

 

About Craven House Capital:

The Company's Investing Policy is primarily to invest in or acquire a portfolio of companies, partnerships, joint ventures, businesses or other assets participating in the e-Commerce sector.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBSBDBCXBDGDU